China health sector sees better sentiment from anti-graft drive: Executives
According to Larry Merizalde, China CEO of South African manufacturer Aspen, “we’ve seen some disturbance in our ability to implement some clinical application actions and in the ability of our health representatives to attend hospitals.” AstraZeneca was likewise “facing challenges from the medical anti-corruption investigations in China, reducing AZN’s exposureContinue Reading